Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19001327 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Combination Chemotherapy With or Without Interleukin-2 and Interferon Alfa in Treating Patients With Metastatic Melanoma
Condition: Melanoma (Skin)
Interventions: Biological: aldesleukin;   Biological: filgrastim;   Biological: recombinant interferon alfa;   Drug: cisplatin;   Drug: dacarbazine;   Drug: vinblastine

Indicates status has not been verified in more than two years